Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Diabetologia 55 (4), 948958
PMC 8294388
An assortment of epidemiological and clinical studies have stated glucose and lipid metabolism alterations, insulin resistance, and central obesity as predominant factors for the development of MetS [38, 212]
The SMG group (once 2.4 mg, once a week) was treated for 68 weeks, and the average weight loss in the SMG group was 15.3 kg
PubMed laboratory research record [PMID: 42204242] PubMed record related to this compound for laboratory literature review
US$ 29.79
US$ 20.64
US$ 29.51
US$ 20.85
